XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Earnings
Noncontrolling Interest
Total
Beginning balance at Dec. 28, 2019 $ 61,409 $ 192,173 $ 995,022 $ (4,889) $ 14,018 $ 1,257,733
Increase (Decrease) in Stockholders' Equity            
Net earnings     246,778   7,104 253,882
Foreign currency translation adjustment       1,373 2,872 4,245
Unrealized loss on investment & foreign currency       1,722   1,722
Distributions to NCI         (933) (933)
Redeemable NCI   130     (225) (95)
Cash dividends     (30,669)     (30,669)
Issuance of shares under employee stock purchase plan 35 1,360       1,395
Net issuance (forfeitures) of shares under stock grant programs 390 12,140 5     12,535
Issuance of shares under deferred compensation plans 128 (128)        
Repurchase of shares (756)   (28,456)     (29,212)
Expense associated with share-based compensation arrangements   3,905       3,905
Accrued expense under deferred compensation plans   8,644       8,644
Ending balance at Dec. 26, 2020 61,206 218,224 1,182,680 (1,794) 22,836 1,483,152
Increase (Decrease) in Stockholders' Equity            
Net earnings     535,640   16,724 552,364
Foreign currency translation adjustment       (2,584) (1,685) (4,269)
Unrealized gain (loss) on debt securities       (1,027)   (1,027)
Distributions to NCI         (6,750) (6,750)
NCI related to business combinations         6,831 6,831
Cash dividends     (40,209)     (40,209)
Issuance of shares under employee stock purchase plan 33 2,083       2,116
Net issuance (forfeitures) of shares under stock grant programs 546 3,506 10     4,062
Issuance of shares under deferred compensation plans 117 (117)        
Expense associated with share-based compensation arrangements   11,071       11,071
Accrued expense under deferred compensation plans   9,228       9,228
Ending balance at Dec. 25, 2021 61,902 243,995 1,678,121 (5,405) 37,956 2,016,569
Increase (Decrease) in Stockholders' Equity            
Net earnings     692,651   12,210 704,861
Foreign currency translation adjustment       (1,841) 1,802 (39)
Unrealized gain on investments and other       (1,829)   (1,829)
Distributions to NCI         (12,024) (12,024)
Contributions to NCI         538 538
Redeemable NCI         (7,641) (7,641)
Cash dividends     (58,860)     (58,860)
Issuance of shares under employee stock purchase plan 44 2,725       2,769
Net issuance (forfeitures) of shares under stock grant programs 806 9,919 25     10,750
Issuance of shares under deferred compensation plans 113 (113)        
Repurchase of shares (1,247)   (94,527)     (95,774)
Expense associated with share-based compensation arrangements   27,987       27,987
Accrued expense under deferred compensation plans   9,516       9,516
Ending balance at Dec. 31, 2022 $ 61,618 $ 294,029 $ 2,217,410 $ (9,075) $ 32,841 $ 2,596,823